Matarin Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-1,707
Closed -$239K 306
2017
Q4
$239K Buy
1,707
+31
+2% +$4.32K 0.02% 281
2017
Q3
$218K Buy
+1,676
New +$222K 0.02% 278
2017
Q1
Sell
-26,323
Closed -$3.03M 300
2016
Q4
$3.03M Sell
26,323
-59,361
-69% -$6.86M 0.34% 119
2016
Q3
$10.1M Buy
85,684
+28,624
+50% +$3.47M 1.12% 7
2016
Q2
$6.92M Buy
57,060
+5,708
+11% +$649K 0.94% 17
2016
Q1
$5.56M Hold
51,352
0.78% 45
2015
Q4
$5.27M Buy
51,352
+41,908
+444% +$4.21M 0.79% 41
2015
Q3
$882K Sell
9,444
-4,918
-34% -$476K 0.18% 146
2015
Q2
$1.4M Buy
+14,362
New +$1.44M 0.4% 109

Other funds holding JNJ

Matarin Capital Management's JNJ Position: Q1 2018 in Review

Matarin Capital Management sold out of Johnson & Johnson (JNJ) in Q1 2018, closing a stake of 1,707 shares — an estimated $239K sold.

Matarin Capital Management first reported a position in JNJ in Q2 2015 and held it in 9 quarters. The position peaked at $10.1M in Q3 2016. 2,599 funds tracked by Wall St. Rank hold JNJ as of Q1 2018.

  • Matarin Capital Management reported no remaining Johnson & Johnson position as of Q1 2018 after selling out during the quarter.
  • Matarin Capital Management sold 1,707 Johnson & Johnson shares in Q1 2018, an estimated $239K.
  • Matarin Capital Management first reported a position in Johnson & Johnson in Q2 2015 and held it in 9 quarters.
  • Matarin Capital Management's Johnson & Johnson position peaked at $10.1M in Q3 2016.
  • 2,599 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2018.

Based on Matarin Capital Management's 13F filing for Q1 2018, filed 10 May 2018.